Annual ROE:
29.38%+8.63%(+41.59%)Summary
- As of today, CPRX annual return on equity is 29.38%, with the most recent change of +8.63% (+41.59%) on December 31, 2024.
- During the last 3 years, CPRX annual ROE has risen by +8.40% (+40.04%).
- CPRX annual ROE is now -49.61% below its all-time high of 58.30%, reached on December 31, 2020.
Performance
CPRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
28.60%-0.83%(-2.82%)Summary
- As of today, CPRX quarterly return on equity is 28.60%, with the most recent change of -0.83% (-2.82%) on June 30, 2025.
- Over the past year, CPRX quarterly ROE has increased by +13.67% (+91.56%).
- CPRX quarterly ROE is now -57.34% below its all-time high of 67.04%, reached on September 30, 2020.
Performance
CPRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CPRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +41.6% | +91.6% |
| 3Y3 Years | +40.0% | +10.8% |
| 5Y5 Years | -36.2% | -39.8% |
CPRX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -10.3% | +41.6% | -24.7% | +91.6% |
| 5Y | 5-Year | -49.6% | +41.6% | -57.3% | +91.6% |
| All-Time | All-Time | -49.6% | +104.6% | -57.3% | +102.0% |
CPRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 28.60%(-2.8%) |
| Mar 2025 | - | 29.43%(+5.8%) |
| Dec 2024 | 29.38%(+41.6%) | 27.81%(0.0%) |
| Sep 2024 | - | 27.81%(+86.3%) |
| Jun 2024 | - | 14.93%(-8.0%) |
| Mar 2024 | - | 16.22%(-20.7%) |
| Dec 2023 | 20.75%(-36.7%) | 20.45%(+7.3%) |
| Sep 2023 | - | 19.05%(-49.9%) |
| Jun 2023 | - | 38.00%(+4.4%) |
| Mar 2023 | - | 36.40%(+8.5%) |
| Dec 2022 | 32.76%(+56.1%) | 33.54%(+14.0%) |
| Sep 2022 | - | 29.43%(+14.0%) |
| Jun 2022 | - | 25.81%(+13.8%) |
| Mar 2022 | - | 22.68%(+8.3%) |
| Dec 2021 | 20.98%(-64.0%) | 20.94%(-10.2%) |
| Sep 2021 | - | 23.31%(-49.7%) |
| Jun 2021 | - | 46.35%(-8.1%) |
| Mar 2021 | - | 50.45%(-15.9%) |
| Dec 2020 | 58.30%(+26.6%) | 60.01%(-10.5%) |
| Sep 2020 | - | 67.04%(+41.2%) |
| Jun 2020 | - | 47.49%(-16.0%) |
| Mar 2020 | - | 56.55%(+17.4%) |
| Dec 2019 | 46.06%(+189.2%) | 48.17%(+213.4%) |
| Sep 2019 | - | 15.37%(+176.8%) |
| Jun 2019 | - | -20.01%(+56.7%) |
| Mar 2019 | - | -46.19%(+6.8%) |
| Dec 2018 | -51.62%(-68.6%) | -49.55%(-29.0%) |
| Sep 2018 | - | -38.40%(-6.3%) |
| Jun 2018 | - | -36.11%(+2.7%) |
| Mar 2018 | - | -37.10%(+10.9%) |
| Dec 2017 | -30.62%(+19.7%) | -41.64%(+11.3%) |
| Sep 2017 | - | -46.96%(-9.4%) |
| Jun 2017 | - | -42.93%(-4.2%) |
| Mar 2017 | - | -41.21%(-7.0%) |
| Dec 2016 | -38.13%(+14.5%) | -38.53%(+0.0%) |
| Sep 2016 | - | -38.54%(-5.1%) |
| Jun 2016 | - | -36.66%(-7.4%) |
| Mar 2016 | - | -34.13%(+5.3%) |
| Dec 2015 | -44.61%(+18.6%) | -36.03%(-5.4%) |
| Sep 2015 | - | -34.18%(+10.2%) |
| Jun 2015 | - | -38.08%(+12.2%) |
| Mar 2015 | - | -43.35%(+15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -54.77%(+18.9%) | -50.99%(-6.0%) |
| Sep 2014 | - | -48.12%(+24.4%) |
| Jun 2014 | - | -63.63%(+24.9%) |
| Mar 2014 | - | -84.74%(-12.8%) |
| Dec 2013 | -67.50%(-52.2%) | -75.13%(+4.8%) |
| Sep 2013 | - | -78.93%(-10.7%) |
| Jun 2013 | - | -71.31%(-38.8%) |
| Mar 2013 | - | -51.36%(+7.0%) |
| Dec 2012 | -44.35%(+67.8%) | -55.23%(+54.5%) |
| Sep 2012 | - | -121.41%(-8.5%) |
| Jun 2012 | - | -111.85%(+19.0%) |
| Mar 2012 | - | -138.10%(-5.4%) |
| Dec 2011 | -137.76%(-125.8%) | -131.01%(-46.3%) |
| Sep 2011 | - | -89.52%(-11.0%) |
| Jun 2011 | - | -80.66%(-7.6%) |
| Mar 2011 | - | -74.97%(-16.8%) |
| Dec 2010 | -61.00%(+23.4%) | -64.20%(+11.9%) |
| Sep 2010 | - | -72.90%(+8.0%) |
| Jun 2010 | - | -79.26%(+1.4%) |
| Mar 2010 | - | -80.41%(+18.8%) |
| Dec 2009 | -79.68%(-1.4%) | -98.97%(+13.3%) |
| Sep 2009 | - | -114.14%(-2.2%) |
| Jun 2009 | - | -111.66%(-11.7%) |
| Mar 2009 | - | -100.00%(-30.1%) |
| Dec 2008 | -78.60%(-243.4%) | -76.88%(-49.3%) |
| Sep 2008 | - | -51.51%(-44.4%) |
| Jun 2008 | - | -35.66%(-35.9%) |
| Mar 2008 | - | -26.24%(-14.1%) |
| Dec 2007 | -22.89%(+14.9%) | -22.99%(+10.6%) |
| Sep 2007 | - | -25.71%(+32.6%) |
| Jun 2007 | - | -38.14%(-7.7%) |
| Mar 2007 | - | -35.40%(+3.0%) |
| Dec 2006 | -26.90%(+95.8%) | -36.50%(+88.3%) |
| Sep 2006 | - | -311.96%(+73.9%) |
| Jun 2006 | - | -1193.21%(-108.3%) |
| Mar 2006 | - | -572.86%(+11.3%) |
| Dec 2005 | -640.10%(-184.7%) | -646.18%(+55.3%) |
| Sep 2005 | - | -1444.30%(-6.7%) |
| Jun 2005 | - | -1353.40%(-49.3%) |
| Mar 2005 | - | -906.29%(-97.4%) |
| Dec 2004 | -224.82%(-6.9%) | -459.18% |
| Dec 2003 | -210.36%(+63.1%) | - |
| Dec 2002 | -569.93% | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of CPRX is 29.38%
What is the all-time high annual ROE for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual return on equity is 58.30%
What is Catalyst Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, CPRX annual return on equity has changed by +8.63% (+41.59%)
What is Catalyst Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of CPRX is 28.60%
What is the all-time high quarterly ROE for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly return on equity is 67.04%
What is Catalyst Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, CPRX quarterly return on equity has changed by +13.67% (+91.56%)